Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

NCT07497438 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytosis

Interventions

DRUG: Etoposide (Early strategy)
DRUG: Etoposide (Delayed strategy)

Sponsor

Assistance Publique - Hôpitaux de Paris